Soleno Therapeutics, Inc. Detailed Financials

Full historical quarterly statements

Metric	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Total Revenue	94.6M	91.7M	66.0M	32.7M	0	0	0	0
Cost of Goods Sold	1.2M	863K	1.1M	696K	0	0	0	494K
Gross Profit	93.4M	90.9M	64.9M	32.0M	0	0	0	-494K
R&D Expenses	11.3M	9.6M	8.4M	9.1M	13.5M	21.5M	30.1M	12.3M
Operating Expenses	61.6M	50.4M	42.8M	38.5M	45.7M	59.1M	80.2M	22.7M
Operating Income	31.8M	40.4M	22.1M	-6.5M	-45.7M	-59.1M	-80.2M	-23.2M
Other Income / Gains	3.2M	2.9M	3.9M	1.8M	2.0M	3.1M	3.6M	1.4M
Net Income	31.4M	43.4M	26.0M	-4.7M	-43.8M	-56.0M	-76.6M	-21.9M
EPS (Diluted)	0.60	0.96	0.49	-0.093	-0.95	-1.27	-1.83	-0.57
Reported Currency	USD	USD	USD	USD	USD	USD	USD	USD
Gross Profit Ratio	0.987	0.991	0.983	0.979	0	0	0	0
General And Administrative Expenses	0	0	0	28.2M	29.3M	37.3M	49.2M	10.9M
Selling And Marketing Expenses	0	0	0	0	0	0	0	-494K
Selling General And Administrative Expenses	50.4M	40.9M	33.8M	28.2M	29.3M	37.3M	49.2M	10.4M
Other Expenses	0	0	614K	1.1M	3.0M	327K	877K	0
Cost And Expenses	62.8M	51.3M	43.9M	39.2M	45.7M	59.1M	80.2M	23.2M
Interest Income	4.9M	5.1M	5.3M	3.2M	3.3M	3.4M	3.6M	3.0M
Interest Expense	1.3M	1.3M	1.4M	1.4M	1.4M	0	0	0
Depreciation And Amortization	514K	509K	502K	502K	504K	503K	500K	494K
Ebitda	32.3M	45.2M	27.9M	-2.8M	-41.9M	-49.5M	-78.8M	-22.7M
Ebitdaratio	0.341	0.493	0.423	-0.087	0	0	0	0
Operating Income Ratio	0.336	0.441	0.335	-0.20	0	0	0	0
Income Before Tax	34.9M	43.4M	26.0M	-4.7M	-43.8M	-56.0M	-76.6M	-21.9M
Income Before Tax Ratio	0.369	0.473	0.394	-0.144	0	0	0	0
Income Tax Expense	3.5M	0	0	0	0	0	0	0
Net Income Ratio	0.332	0.473	0.394	-0.144	0	0	0	0
Epsdiluted	0.59	0.80	0.47	-0.093	-0.95	-1.27	-1.83	-0.57
Weighted Average Shs Out	52.1M	53.2M	53.3M	50.5M	46.2M	43.9M	41.9M	38.6M
Weighted Average Shs Out Dil	53.1M	54.3M	54.9M	50.5M	46.2M	43.9M	41.9M	38.6M